XLIFE SCIENCES AG |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.8 EUR | -0.48% |
|
-7.52% | -3.69% |
| 04-23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
| 02-29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 63.85B | - | |||||
| 41.83B | ||||||
| 40.65B | ||||||
| 27.12B | ||||||
| 26.52B |
